Danièle Guyot-Caparros is a chartered accountant and graduate from the Ecole Supérieure de Commerce in Nancy.

Danièle Guyot-Caparros is graduated from the Ecole Supérieure de Commerce of Nancy in finance and accounting. Following international missions in Audit, she joined Rhone Poulenc (now Sanofi) where she has held different positions with an increasing scope of responsibilities in finance on a European level and in business planning and performance monitoring on a worldwide level. Danièle Guyot-Caparros has been working as a consultant specialized in life sciences and healthcare areas for 5 years.

Danièle Guyot-Caparros has been a director of Onxeo since 26 June 2013 and Chairperson of the Board of Directors since 22 May 2019.. Her mandate will expire at the annual shareholders’ general meeting of 2019.

Thomas Hofstaetter holds a PhD in Molecular Biology.

He carried out his international career, especially in Germany, the United States and Japan, within international pharmaceutical  groups (Wyeth, Aventis, etc.) on strategic  positions at the highest level in external growth and business development. Over the past two years, until December 2011, he headed VaxInnate Corporation and is now Board Member of Bionor ASA.

Thomas Hofstaetter has been a director of Onxeo since 31 May 2012. His mandate will expire at the shareholders’ annual general meeting of 2021.

Christine Garnier is co-founder of the firm AEC Partners and is Managing Partner since 1998. She graduated from ESCP Europe in 1984. Her consultant activity is specialized in corporate, international and operational strategies, evolutions in business models and organizations, and the optimization of performance across the life science industry. During the last twenty years, Christine Garnier has managed more than 200 assignments on primary and specialty care products, vaccine products, as well as medical device and OTC. She accompanies executive committees and operational and functional management in the development of vision, their strategies and the evolution of their organizations. The perimeters of her interventions concentrate on Europe and fast developing countries (South East Asia, Latin America…) as well as international and corporate headquarters. She provides her clients with a strong expertise in strategy and organization coupled by her skill to identify and initiate necessary transformations. Before joining AEC Partners, Christine Garnier previously worked for 12 years in the pharmaceutical industry holding marketing positions in Wyeth and international marketing and strategic planning at Rhone Poulenc Rorer.